Literature DB >> 27400297

Addition of TGF-β1 to existing clinical risk scores does not improve prediction for arrhythmia recurrences after catheter ablation of atrial fibrillation.

Jelena Kornej1, Laura Ueberham2, Josephin Schmidl2, Daniela Husser2, Volker Adams3, Gerhard Hindricks2, Andreas Bollmann2.   

Abstract

Entities:  

Keywords:  Atrial fibrillation; Catheter ablation; Fibrosis; Recurrences; Scores; TGF-β1

Mesh：

Substances：

Year:  2016        PMID： 27400297     DOI： 10.1016/j.ijcard.2016.06.290

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  4 in total

Review 1.  [Biomarkers and atrial fibrillation : Prediction of recurrences and thromboembolic events after rhythm control management].

Authors:  Jelena Kornej; Katja Schumacher; Daniela Husser; Gerhard Hindricks
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-05-14

2.  The Expression of BNP, ET-1, and TGF-β1 in Myocardium of Rats with Ventricular Arrhythmias.

Authors:  Meihui Tian; Ying Xiao; Jiajia Xue; Yuan Zhang; Yuqing Jia; Xinyi Luo; Tianqi Wang; Baoli Zhu; Zhipeng Cao
Journal:  Int J Mol Sci       Date:  2019-11-21       Impact factor: 5.923

3.  Are the atrial natriuretic peptides a missing link predicting low-voltage areas in atrial fibrillation? Introducing the novel biomarker-based atrial fibrillation substrate prediction (ANP) score.

Authors:  Timm Seewöster; Petra Büttner; Samira Zeynalova; Gerhard Hindricks; Jelena Kornej
Journal:  Clin Cardiol       Date:  2020-05-27       Impact factor: 2.882

4.  The Role of Pro-Fibrotic Biomarkers in Atrial Fibrillation: How Good Are We in the Translational Interpretation?

Authors:  Jelena Kornej; Andreas Bollmann
Journal:  JACC Basic Transl Sci       Date:  2016-10-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.